Edenbridge Pharmaceuticals, LLC

FDA Regulatory Profile

Edenbridge Pharmaceuticals, LLC appears in FDA public data with 1 recall, 0 510(k) clearances, 1 FDA inspection, and 0 compliance actions on record. Its most recent recall (D-0080-2024, Class III) was initiated on October 20, 2023.

Summary

Total Recalls
1
510(k) Clearances
0
Inspections
1
Compliance Actions
0

Recent Recalls

NumberClassProductDate
D-0080-2024Class IIIOpium Tincture, USP (Deodorized), 10 mg/mL of anhydrous morphine, packaged in 118 mL (4 Fl oz) bottlOctober 20, 2023